21139-31-1

Basic information

• Product Name: 5-CHLORO-3-PHENYL-1H-INDOLE-2-CARBOXYLIC ACID
• Synonyms: CHEMBRDG-BB 4400278;5-CHLORO-3-PHENYL-1H-INDOLE-2-CARBOXYLIC ACID;5-chloro-3-phenyl-1H-indole-2-carboxylic acid(SALTDATA: FREE);5-Chloro-3-Phenyl-1H-Indole-2-Carboxylic Acid≥ 95% (NMR)
• CAS NO: 21139-31-1
• Molecular Formula: C₁₅H₁₀ClNO₂
• Molecular Weight: 271.7
• Mol File: 21139-31-1.mol
• Article Data: 5

Chemical Properties

• Melting Point: 230-232°C
• Boiling Point: 500.7 °C at 760 mmHg
• Flash Point: 256.6 °C
• Appearance: /
• Density: 1.417 g/cm³
• Vapor Pressure: 7.6E-11mmHg at 25°C
• PKA: 3.52±0.30(Predicted)
• CAS DataBase Reference: 5-CHLORO-3-PHENYL-1H-INDOLE-2-CARBOXYLIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: 5-CHLORO-3-PHENYL-1H-INDOLE-2-CARBOXYLIC ACID(21139-31-1)
• EPA Substance Registry System: 5-CHLORO-3-PHENYL-1H-INDOLE-2-CARBOXYLIC ACID(21139-31-1)

Safety Data

• Hazard Codes: Xn
• Statements: 22
• HazardClass: IRRITANT
• Hazardous Substances Data: 21139-31-1(Hazardous Substances Data)

Usage

Chemical Properties

Yellow crystalline powder

InChI:InChI=1/C15H10ClNO2/c16-10-6-7-12-11(8-10)13(14(17-12)15(18)19)9-4-2-1-3-5-9/h1-8,17H,(H,18,19)/p-1

Upstream product

• 46115-41-7 phenyl pyruvic acid 
• 21139-32-2 ethyl 3-phenyl-5-chloroindole-2-carboxylate 
• 93704-68-8 ethyl 3-bromo-5-chloroindole-2-carboxylate 
• 4792-67-0 5-chloro-indole-2-carboxylic acid ethyl ester 

Downstream Products

• 1250441-90-7 5-chloro-N-[2-(4-methylpiperazin-1-yl)ethyl]-3-phenyl-1H-indole-2-carboxamide 
• 120608-12-0 2-[(5-Chloro-3-phenyl-1H-indole-2-carbonyl)-amino]-benzoic acid ethyl ester 
• 120608-21-1 2-Chloro-13-phenyl-11H-benzo[5,6][1,4]diazepino[1,2-a]indole-6,12-dione 
• 24107-01-5 5-chloro-3-phenyl-1H-indole-2-carbonyl chloride 

Relevant articles and documents

Design, synthesis and pharmacophoric model building of new 3-alkoxymethyl/3-phenyl indole-2-carboxamides with potential antiproliferative activity

Novel 3-alkoxymethyl/3-phenyl indole-2-carboxamide derivatives were synthesized and evaluated for their anticancer activity. Most of the tested compounds showed moderate to excellent activity against the tested cell lines (MCF7 and HCT116). 3-Phenyl substitution on indole with p-piperidinyl phenethyl 24a and p-dimethylamino phenethyl 24c exhibited anticancer activity against MCF7 with IC50 of 0.13 and 0.14?μm, respectively. Further mechanistic study of the most active compounds through their action on cell cycle showed disturbance in cell cycle progression and cell cycle arrest. For future development of this series of compounds, pharmacophore study was conducted which indicated that the enhancement of the activity could be achieved through the addition of acceptor or donating groups to the already-present indole nucleus.

NOVEL NEUROTRYPSIN INHIBITORS

The invention relates to novel acylamino-hydroxy-benzamides of formula (I), wherein R1 is phenyl substituted by phenyl, phenoxy, phenylamino or heteroaryl, all optionally further substituted; bicyclic aryl, monocyclic heteroaryl substituted by

The synthesis and transformations of some 3 chloro and 3 nitroindolenines

-